Track Real Time Price

According to ChemAnalyst, The Zidovudine Prices recorded an upward movement across major global regions during the second quarter of 2026, supported by firm pharmaceutical demand, higher production expenses, and fluctuations in raw material and energy costs. Zidovudine, also known as azidothymidine (AZT), remains an established antiretroviral pharmaceutical compound used in HIV treatment, including combination therapy. Although newer antiretroviral medicines have become increasingly important in HIV treatment protocols, Zidovudine continues to maintain demand across selected pharmaceutical applications and markets. During Q2 2026, the global Zidovudine market experienced a combination of demand-side and cost-side pressures. Pharmaceutical manufacturers and suppliers faced higher operating expenses in several markets, while energy and raw material price volatility affected production economics. These factors contributed to an increase in the Zidovudine Price Index in North America, As...

  According to ChemAnalyst, global Zidovudine prices recorded a significant upward trend across key markets during the first quarter of 2026, supported by increasing production expenses, ongoing supply chain challenges, and steady demand from the pharmaceutical industry. As a vital antiretroviral drug widely used in the treatment and prevention of HIV, Zidovudine continues to play an essential role in healthcare systems worldwide. Throughout the quarter, market participants closely tracked fluctuations in raw material costs, manufacturing conditions, inflationary pressures, and government healthcare programs, all of which contributed to movements in the Zidovudine Price Index. Zidovudine Prices Analysis – Q1 2026 Overview of Global Zidovudine Market Trends The global Zidovudine market witnessed an upward pricing trajectory during Q1 2026 as manufacturers encountered increasing production expenses and supply chain challenges. Rising energy costs, inflationary pressures, transportat...